- Home
- PHAT vs CPZ Comparison
PHAT vs CPZ Comparison
Compare PHAT & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- CPZ
- Stock Information
- Founded
- PHAT 2018
- CPZ 2019
- Country
- PHAT United States
- CPZ United States
- Employees
- PHAT N/A
- CPZ N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- CPZ Trusts Except Educational Religious and Charitable
- Sector
- PHAT Health Care
- CPZ Finance
- Exchange
- PHAT Nasdaq
- CPZ Nasdaq
- Market Cap
- PHAT 339.8M
- CPZ 300.6M
- IPO Year
- PHAT 2019
- CPZ N/A
- Fundamental
- Price
- PHAT $3.96
- CPZ $14.90
- Analyst Decision
- PHAT Strong Buy
- CPZ
- Analyst Count
- PHAT 5
- CPZ 0
- Target Price
- PHAT $22.50
- CPZ N/A
- AVG Volume (30 Days)
- PHAT 1.2M
- CPZ 63.0K
- Earning Date
- PHAT 05-08-2025
- CPZ 01-01-0001
- Dividend Yield
- PHAT N/A
- CPZ 11.07%
- EPS Growth
- PHAT N/A
- CPZ N/A
- EPS
- PHAT N/A
- CPZ N/A
- Revenue
- PHAT $55,252,000.00
- CPZ N/A
- Revenue This Year
- PHAT $202.23
- CPZ N/A
- Revenue Next Year
- PHAT $113.81
- CPZ N/A
- P/E Ratio
- PHAT N/A
- CPZ N/A
- Revenue Growth
- PHAT 8001.47
- CPZ N/A
- 52 Week Low
- PHAT $3.81
- CPZ $13.17
- 52 Week High
- PHAT $19.71
- CPZ $16.11
- Technical
- Relative Strength Index (RSI)
- PHAT 37.83
- CPZ 40.58
- Support Level
- PHAT $3.87
- CPZ $14.77
- Resistance Level
- PHAT $5.09
- CPZ $15.20
- Average True Range (ATR)
- PHAT 0.59
- CPZ 0.43
- MACD
- PHAT -0.10
- CPZ -0.02
- Stochastic Oscillator
- PHAT 6.12
- CPZ 36.65
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.